The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
<p>Abstract</p> <p>Purpose</p> <p>Glioblastoma multiforme (GBM) is resistant to current cytotoxic therapies, in part because of enhanced DNA repair. Activation of the receptor tyrosine kinase c-Met has been shown to protect cancer cells from DNA damage. We hypothesized...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-12-01
|
| Series: | Radiation Oncology |
| Online Access: | http://www.ro-journal.com/content/4/1/69 |